Division Bench confirms injunction against Glenmark from using INDAMET

Brief Facts: Sun Pharma Laboratories found Glenmark’s mark INDAMET, an asthma drug, to be deceptively similar to its registered and prior used trade mark ISTAMET, a diabetes drug. On 3rd July, 2023, the Learned Single Judge of the Delhi High Court, Hon`ble Justice Sanjeev Narula, restrained Glenmark from manufacturing, selling, or advertising its drug under…